{"database": "lobbying", "table": "lobbying_activities", "is_view": false, "human_description_en": "where filing_uuid = \"e86e2c46-950b-485d-b41e-eccb79174d92\" and issue_code = \"PHA\" sorted by filing_year descending", "rows": [[3237784, "e86e2c46-950b-485d-b41e-eccb79174d92", "Q3", "NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)", 28264, "NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)", 2024, "third_quarter", "PHA", "Pharmaceutical issues impacting patients with rare diseases. Orphan Drug Act. H.R.7383/S.1214: RARE Act. Inflation Reduction Act Implementation. PRV Reauthorization. Lab-developed tests.", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 60000, 0, 0, "2024-10-15T10:45:24-04:00"]], "truncated": false, "filtered_table_rows_count": 1, "expanded_columns": [], "expandable_columns": [[{"column": "filing_uuid", "other_table": "lobbying_filings_raw", "other_column": "filing_uuid"}, "registrant_name"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, filing_uuid, filing_type, registrant_name, registrant_id, client_name, filing_year, filing_period, issue_code, specific_issues, government_entities, income_amount, expense_amount, is_no_activity, is_termination, received_date from lobbying_activities where \"filing_uuid\" = :p0 and \"issue_code\" = :p1 order by filing_year desc limit 101", "params": {"p0": "e86e2c46-950b-485d-b41e-eccb79174d92", "p1": "PHA"}}, "facet_results": {"issue_code": {"name": "issue_code", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_uuid=e86e2c46-950b-485d-b41e-eccb79174d92&issue_code=PHA", "results": [{"value": "PHA", "label": "PHA", "count": 1, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=e86e2c46-950b-485d-b41e-eccb79174d92", "selected": true}], "truncated": false}, "filing_year": {"name": "filing_year", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_uuid=e86e2c46-950b-485d-b41e-eccb79174d92&issue_code=PHA", "results": [{"value": 2024, "label": 2024, "count": 1, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=e86e2c46-950b-485d-b41e-eccb79174d92&issue_code=PHA&filing_year=2024", "selected": false}], "truncated": false}, "filing_period": {"name": "filing_period", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_uuid=e86e2c46-950b-485d-b41e-eccb79174d92&issue_code=PHA", "results": [{"value": "third_quarter", "label": "third_quarter", "count": 1, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=e86e2c46-950b-485d-b41e-eccb79174d92&issue_code=PHA&filing_period=third_quarter", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "received_date", "type": "date", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=e86e2c46-950b-485d-b41e-eccb79174d92&issue_code=PHA&_facet_date=received_date"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 81.81175193749368, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}